Dalotuzumab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Dalotuzumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetIGF-1 receptor
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
ECHA InfoCard100.205.569 Edit this at Wikidata
Chemical and physical data
FormulaC6528H10086N1730O2018S40
Molar mass146.4 kg/mol g·mol−1
 ☒N☑Y (what is this?)  (verify)

Dalotuzumab is a humanized monoclonal antibody designed for the treatment of cancers.[1]

Dalotuzumab was developed by Merck & Co., Inc.

References[edit]

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Dalotuzumab" (PDF). American Medical Association.